|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1.155 USD | +5.00% |
|
+14.71% | -19.78% |
| 11-07 | The Beauty Health Company, Q3 2025 Earnings Call, Nov 06, 2025 | |
| 11-07 | Beauty Health Q3 revenue down 10.3%, but beats estimates | RE |
| Capitalization | 140M 121M 109M 105M 192M 12.93B 199M 1.29B 515M 6.17B 526M 515M 22.02B | P/E ratio 2025 * |
-14.7x | P/E ratio 2026 * | -8.65x |
|---|---|---|---|---|---|
| Enterprise value | 289M 248M 225M 216M 394M 26.61B 409M 2.65B 1.06B 12.69B 1.08B 1.06B 45.32B | EV / Sales 2025 * |
0.97x | EV / Sales 2026 * | 0.95x |
| Free-Float |
91.35% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: The Beauty Health Company
| 1 day | +5.00% | ||
| 1 week | +14.71% | ||
| Current month | +7.21% | ||
| 1 month | -13.57% | ||
| 3 months | -23.63% | ||
| 6 months | -45.61% | ||
| Current year | -19.78% |
| 1 week | 0.95 |  | 1.13 |
| 1 month | 0.87 | | 1.32 |
| Current year | 0.87 | | 1.64 |
| 1 year | 0.78 | | 2.69 |
| 3 years | 0.78 | | 13.9 |
| 5 years | 0.78 | | 30.17 |
| 10 years | 0.78 | | 30.17 |
| Manager | Title | Age | Since |
|---|---|---|---|
Michael Monahan
DFI | Director of Finance/CFO | 53 | 10/08/2023 |
Sheri Lewis
COO | Chief Operating Officer | 60 | 09/04/2024 |
Celeste Ortiz
HRO | Human Resources Officer | - | 01/07/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Brenton Saunders
CHM | Chairman | 56 | 04/05/2021 |
Michael Capellas
BRD | Director/Board Member | 71 | 04/05/2021 |
Michelle Kerrick
BRD | Director/Board Member | 63 | 04/05/2021 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +5.00% | +14.71% | -13.57% | -90.71% | 140M | |
| -0.60% | -6.37% | +2.13% | -1.61% | 232B | |
| +6.53% | +5.48% | +37.12% | - | 44.05B | |
| -1.94% | -5.94% | -4.50% | +23.71% | 18.28B | |
| +1.13% | -4.25% | +6.78% | -52.42% | 7.65B | |
| -9.52% | -20.13% | +8.38% | -13.93% | 5.32B | |
| +1.13% | -15.86% | +23.15% | +10.49% | 4.74B | |
| -0.06% | -6.48% | -20.28% | -49.18% | 3.83B | |
| -0.77% | -10.38% | -29.84% | -32.52% | 3.02B | |
| +0.36% | -10.47% | +54.23% | +101.61% | 2.86B | |
| Average | +0.21% | -5.12% | +6.36% | -11.62% | 32.22B | |
| Weighted average by Cap. | +0.31% | -5.63% | +6.95% | -1.35% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 297M 255M 231M 222M 405M 27.33B 420M 2.72B 1.09B 13.04B 1.11B 1.09B 46.56B | 309M 266M 241M 231M 422M 28.48B 437M 2.83B 1.13B 13.58B 1.16B 1.13B 48.52B |
| Net income | -7.46M -6.42M -5.82M -5.59M -10.2M -688M -10.57M -68.43M -27.4M -328M -28.02M -27.42M -1.17B | -17.14M -14.74M -13.38M -12.83M -23.43M -1.58B -24.27M -157M -62.92M -754M -64.35M -62.97M -2.69B |
| Net Debt | 148M 128M 116M 111M 203M 13.68B 210M 1.36B 545M 6.52B 557M 545M 23.3B | 154M 133M 120M 116M 211M 14.23B 219M 1.42B 567M 6.79B 579M 567M 24.24B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/03/26 | 1.125 $ | +2.27% | 36,945 |
| 04/03/26 | 1.100 $ | +1.85% | 1,118,970 |
| 03/03/26 | 1.080 $ | 0.00% | 1,240,694 |
| 02/03/26 | 1.080 $ | +3.85% | 1,168,576 |
| 27/02/26 | 1.040 $ | +7.00% | 1,017,850 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- SKIN Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition